In a literature report, a physician reported that ophthalmic oil was injected into a patient's right eye during a combination cataract and vitrectomy surgery after which the patient experienced elevated intraocular pressure (iop), vision loss and phthisis bulbi which was attributed to migration of the oil product from the eyeball into the right optic nerve and optic chiasm then passing through and into the subarachnoid space.
|
No lot code was reported by the customer therefore, lot specific evaluation cannot be completed.All compounding, preprocessing, filling and packaging mbrs are subjected to 2 independent reviews.In addition, the following are reviewed: all chemistry and microbial finished product results; environmental, utility, bioburden records; sanitization record; sterilization cycles.The reported ophthalmic oil is compounded by (1) chemical and thermal extraction, and (2) sterile filtration of oil prior to filling.The product is then filled into its primary packaging components using aseptic processing.The reported ophthalmic oil is filled into 10ml glass bottles and the stoppers are made from silicone.The product is terminally sterilized using dry heat.Following sterilization, units are 200% inspected for particulate in the solution and then packaged into pouches and sealed.The root cause of the reported complaint condition could not be determined.Potential root cause includes: solution quality issue: highly unlikely, as chemistry and microbiology data is reviewed and verified to meet regulatory requirements prior to release.Consumer mishandling: no conclusion can be made regarding the contribution of consumer mishandling as this factor is outside the control of the manufacturing facility.The product labeling for the reported ophthalmic oil provides indications for use, contraindications, warnings, precautions and directions for use to ensure proper use of the product.Surgical technique, product handling and storage are unknown.Lot specific evaluation is not possible without the lot code being reported.No further action is warranted at this time.The manufacturer internal reference number is: (b)(4).
|